Sign in Subscribe
Vaccines

Global Human Papillomavirus Vaccine Market to Reach USD 4.47 Bn by 2026

Strategic Insights

— 1 min read

The global human papillomavirus (HPV) vaccine market is expected to grow at a compound annual growth rate (CAGR) of 6.6 percent, driven by the rising incidence of HPV-associated cancers and increasing demand for prevention. The market is estimated to be USD 3.25 Bn in 2021 and is expected to reach USD 4.47 Bn by 2026. The HPV vaccine market is driven by government initiatives in HPV vaccination programs, with around 55 percent of WHO Member States introducing HPV vaccination since June 2020. However, stringent government regulations and lower adoption rates of vaccines are expected to hamper market growth.

Key Takeaways:

  • The global HPV vaccine market is expected to reach USD 4.47 Bn by 2026, growing at a CAGR of 6.6 percent.
  • The market is driven by the rising incidence of HPV-associated cancers and increasing demand for prevention.
  • Government initiatives in HPV vaccination programs are anticipated to propel market growth, with around 55 percent of WHO Member States introducing HPV vaccination since June 2020.
  • Companies such as Merck & Co., Inc. and GlaxoSmithKline Plc are major players in the market.
  • The competitive quadrant analysis categorizes companies based on their industry position score and market performance score.
  • Stringent government regulations and lower adoption rates of vaccines are expected to hamper market growth.
  • The market is expected to be driven by the introduction of new vaccines and emerging countries' increasing healthcare infrastructure and expenditure.

Statistics:

  • Global HPV vaccine market size: USD 3.25 Bn in 2021
  • Global HPV vaccine market size: USD 4.47 Bn by 2026
  • CAGR: 6.6 percent

*

  • WHO Member States introducing HPV vaccination: around 55 percent since June 2020
  • Government initiatives in HPV vaccination programs: anticipated to propel market growth

Sources:

  • Research and Markets. "Global Human Papillomavirus Vaccine Market (2021-2026) by Type, Indication, Diseases, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis."
  • World Health Organization.

Read more